Pfizer to Present Data on New Approaches to Pain and Inflammation Treatment at ACR Meeting (Business Wire via Yahoo! Finance)

Published on: Sun, 26 Oct 2008 00:00:00 GMT

SAN FRANCISCO----Pfizer will present data on three investigational compounds that represent potential new mechanisms for targeting pain and inflammation. These data will highlight tanezumab, a molecule designed to target nerve growth factor, a key pain mediator; CP-690,550, a JAK-inhibitor that suppresses immune-related inflammatory response; and esreboxetine, a highly-selective norepinephrine ... More »